<DOC>
	<DOCNO>NCT01843205</DOCNO>
	<brief_summary>Methamphetamine use disorder unrelenting public health concern . Intensive research effort yield behavioral intervention reduce methamphetamine use , however , intervention universally effective treatment effect diminish time . Development pharmacotherapy enhances efficacy intervention priority National Institute Drug Abuse . This study propose determine impact buspirone maintenance self-administration methamphetamine . These preliminary data use support research develop buspirone pharmacotherapy methamphetamine use disorder . The investigator hypothesize buspirone attenuate reinforce effect methamphetamine .</brief_summary>
	<brief_title>Buspirone Candidate Medication Methamphetamine Abuse</brief_title>
	<detailed_description />
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Lifetime methamphetamine use Abnormal screening outcome ( e.g. , ECG , blood chemistry result ) study physician deem clinically significant Current past history substance abuse dependence deem study physician interfere study completion History serious physical disease , current physical disease , impair cardiovascular functioning , chronic obstructive pulmonary disease , history seizure current past history serious psychiatric disorder opinion study physician would interfere study participation exclude participation Females currently use effective birth control Contraindications methamphetamine buspirone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>